BCIQ Profiles

Company Profile Report

Fast-growing evergreen

How returns from Ogeda’s exit could affect Fund+’s investment strategy

A larger and earlier than expected payout from Ogeda S.A. could substantially increase the size of Fund+’s evergreen life sciences fund, leading the firm to consider broadening its investment strategy.

On April 3,

Read the full 336 word article

How to gain access

Continue reading with a
two-week free trial.